Desmopressin
Replaces a missing hormone to help your body manage fluid balance. Used for specific endocrine conditions.
This peptide is an FDA-approved drug product that can be legally prescribed by licensed clinicians.
The basics
- Generic Name
- desmopressin acetate (vasopressin analog)
- Brand Names
- DDAVP, Stimate, Nocdurna
- Regulatory Status
- Prescribed by Doctors
- Therapeutic Areas
- Endocrine, Cardiovascular
- Prescribing Specialties
- Endocrinology, Hematology
What it does
Desmopressin is an FDA-approved medication that your doctor can prescribe. Synthetic analog of antidiuretic hormone (vasopressin) that acts on V2 receptors in renal collecting ducts to increase water reabsorption and on endothelial cells to release factor VIII and von Willebrand factor.
How it's taken
Oral tablet
Nasal spray
Subcutaneous injection
How people access it
Prescribed by endocrinologists or primary care. Available in multiple forms at retail pharmacies. Well-established medication.
What doctors prescribe it for
- Central diabetes insipidus
- Hemophilia A (mild to moderate)
- von Willebrand disease type I
- Primary nocturnal enuresis (select formulations)
Clinicians may prescribe FDA-approved drugs for off-label uses based on their clinical judgment. Off-label indications have not undergone the same FDA review process as the labeled uses listed above.
How to know it's legit
You can independently verify the FDA-approval status of Desmopressin through these free, publicly available databases:
- DailyMed (dailymed.nlm.nih.gov) — Search for DDAVP to find the current FDA-approved labeling, including indications, dosing, warnings, and contraindications.
- Drugs@FDA (accessdata.fda.gov/scripts/cder/daf/) — Search to find the original approval letter, review documents, and approval history.
- FDA Orange Book (orangebook.fda.gov) — Search for therapeutic equivalence evaluations and patent/exclusivity information.
Common Questions
Yes. Desmopressin (DDAVP, Stimate, Nocdurna) is an FDA-approved drug product. It has undergone rigorous review of safety, efficacy, and manufacturing quality by the FDA. It can be legally prescribed by licensed clinicians for its approved indications.
Desmopressin is FDA-approved for: Central diabetes insipidus; Hemophilia A (mild to moderate); von Willebrand disease type I; Primary nocturnal enuresis (select formulations). Off-label use may be considered by clinicians on a case-by-case basis, but only the labeled indications have been reviewed and approved by the FDA.
You can verify the approval status of Desmopressin through several official FDA resources: DailyMed (dailymed.nlm.nih.gov) for current labeling, Drugs@FDA (accessdata.fda.gov/scripts/cder/daf/) for approval history, and the FDA Orange Book for therapeutic equivalence information. These are free, publicly available databases.
Want to learn more?
Explore how Desmopressin compares to other options, or dive deeper into how FDA approval works.
Explore All Peptides